Erythropoietin solution formulation

Details Erythropoietin solution formulation Erythropoietin solution formulation

2004-12-01

2008-12-23

Allen, Marianne P (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S397000

Reexamination Certificate

active

07468351

ABSTRACT:
A stable pharmaceutical formulation of erythropoietin is disclosed which contains tris-(hydrox-ymethyl)-aminomethane as stabilizer, whereby the formulation does not contain amino acids or human serumalbumin.

REFERENCES:
patent: 4806524 (1989-02-01), Kawaguchi et al.
patent: 4992419 (1991-02-01), Woog et al.
patent: 5376632 (1994-12-01), Konings et al.
patent: 5656289 (1997-08-01), Cho et al.
patent: 6645522 (2003-11-01), Naeff et al.
patent: 6979442 (2005-12-01), Canning et al.
patent: 2003/0148938 (2003-08-01), Sharma et al.
patent: 2004/0022861 (2004-02-01), Williams et al.
patent: 101 61 577 (2003-07-01), None
patent: 0 456 153 (1991-05-01), None
patent: 0 909 564 (1999-04-01), None
patent: 59078124 (1984-05-01), None
Espada et al. A New Method for Concentration of Erythropoietin from Human Urine. Biochemical Medicine vol. 3, pp. 475-484 (1970).

Affiliated with

Also associated with

Rating

Erythropoietin solution formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythropoietin solution formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin solution formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4047167